Literature DB >> 6498067

Endometrial cancer following treatment for breast cancer: a case-control study in Denmark.

M Ewertz, S G Machado, J D Boice, O M Jensen.   

Abstract

To evaluate the risk of endometrial cancer subsequent to breast cancer, a case-control study was carried out in Denmark. Between 1943-1977, 115 cases of histologically confirmed endometrial carcinoma developed more than 3 months after the diagnosis of a primary breast cancer in 51,638 women. A total of 235 breast cancer patients with no second primary cancer were matched to the cases on age, calendar year of diagnosis, and survival with an intact uterus. Identification of cases and controls relied upon records available in the Danish Cancer Registry. Information on risk factors and reproductive histories was abstracted from hospital records. Increased relative risks (RR) for endometrial cancer were associated with menopausal oestrogen use (RR = 4.9), nulliparity (RR = 2.1), late age at natural menopause (RR = 2.9), and pelvic irradiation (RR = 1.4). No association was apparent for drugs used to treat breast cancer. This study indicates that breast and endometrial cancer share several common aetiologic factors and that studies of second primary cancers have the potential to provide information on risk factors other than those associated with therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498067      PMCID: PMC1976991          DOI: 10.1038/bjc.1984.237

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Risk factors for endometrial cancer.

Authors:  B MacMahon
Journal:  Gynecol Oncol       Date:  1974-08       Impact factor: 5.482

2.  Late results of radium treatment of carcinoma of the cervix.

Authors:  R J Dickson
Journal:  Clin Radiol       Date:  1972-10       Impact factor: 2.350

3.  A computer program for the analysis of matched case-control studies.

Authors:  J H Lubin
Journal:  Comput Biomed Res       Date:  1981-04

4.  An epidemiological investigation of cancer of the endometrium.

Authors:  E L Wynder; G C Escher; N Mantel
Journal:  Cancer       Date:  1966-04       Impact factor: 6.860

5.  Cancer of the uterine corpus after hormonal treatment for breast cancer.

Authors:  R Hoover; J F Fraumeni; R Everson; M H Myers
Journal:  Lancet       Date:  1976-04-24       Impact factor: 79.321

6.  Review of epidemiologic studies of endometrial cancer and exogenous estrogen.

Authors:  D W Cramer; R C Knapp
Journal:  Obstet Gynecol       Date:  1979-10       Impact factor: 7.661

Review 7.  Epidemiology of endometrial cancer.

Authors:  J M Elwood; P Cole; K J Rothman; S D Kaplan
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

8.  Late effects of x irradiation in patients treated for metropathia haemorrhagica.

Authors:  P G Smith; R Doll
Journal:  Br J Radiol       Date:  1976-03       Impact factor: 3.039

9.  Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium.

Authors:  S Shapiro; D W Kaufman; D Slone; L Rosenberg; O S Miettinen; P D Stolley; N B Rosenshein; W G Watring; T Leavitt; R C Knapp
Journal:  N Engl J Med       Date:  1980-08-28       Impact factor: 91.245

10.  Cancer following medical irradiation.

Authors:  J D Boice
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

View more
  4 in total

Review 1.  Carcinoma of the endometrium.

Authors:  B M Southcott
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Multiple primary cancers in Connecticut, 1935-82.

Authors:  J D Boice; R E Curtis; R A Kleinerman; J T Flannery; J F Fraumeni
Journal:  Yale J Biol Med       Date:  1986 Sep-Oct

3.  On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study.

Authors:  H O Adami; U B Krusemo; L Bergkvist; I Persson; B Pettersson
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

4.  Multiple primary cancers in Denmark 1943-80; influence of possible underreporting and suggested risk factors.

Authors:  H H Storm; E Lynge; A Osterlind; O M Jensen
Journal:  Yale J Biol Med       Date:  1986 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.